NEWRON PHARMACEUT. EO-20 Strategic Asset Allocation Index
NEWRON PHARMACEUT. EO-20 strategic asset allocation index. NEWRON PHARMACEUT. EO-20 (NP5) has a Strategic Asset Allocation Index of 18.6% as of December 2021. Strategic assets (PP&E of €577.00K plus long-term investments of €-) total €577.00K, measured against net assets of €3.11 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is NEWRON PHARMACEUT. EO-20's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of NEWRON PHARMACEUT. EO-20 (2016–2021)
Strategic asset allocation index of NEWRON PHARMACEUT. EO-20 from 2016 to 2021. This chart shows how NEWRON PHARMACEUT. EO-20's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2021. As of December 2021, the index stands at 18.6%, representing strategic assets of €577.00K against net assets of €3.11 Million EUR. Check NEWRON PHARMACEUT. EO-20 (NP5) tangible equity ratio to evaluate the tangible quality of the company's equity base.
NEWRON PHARMACEUT. EO-20 Strategic Asset Allocation Index by Year (2016–2021)
NEWRON PHARMACEUT. EO-20 strategic asset allocation index by year from 2016 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for NEWRON PHARMACEUT. EO-20 from 2016 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see NEWRON PHARMACEUT. EO-20 market cap and net worth.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 18.6% | €577.00K | €577.00K | €- | €3.11 Million | ▲ +14.3 pp |
| 2020 | 4.3% | €734.00K | €734.00K | €- | €17.25 Million | ▲ +3.6 pp |
| 2019 | 0.7% | €252.00K | €252.00K | €- | €36.80 Million | ▲ +0.0 pp |
| 2018 | 0.7% | €374.00K | €374.00K | €- | €54.84 Million | ▲ +0.5 pp |
| 2017 | 0.2% | €107.00K | €107.00K | €- | €67.72 Million | ▼ -0.1 pp |
| 2016 | 0.2% | €120.00K | €120.00K | €- | €49.75 Million | — |